Dr. Arndt Schottelius
Chief Development Officer
MorphoSys AG (MOR) - developing innovate cancer treatment antibodies.
MorphoSys develops novel antibodies for therapeutic, diagnostic and research applications. The Company's HuCAL technology is one of the most powerful methods available for generating fully human antibodies. By applying its proprietary technologies, MorphoSys has become a leader in therapeutic antibodies, one of the fastest-growing drug classes in human health-care.